Navigation Links
Keryx Biopharmaceuticals, Inc. to Hold Investor/Analyst Day Tomorrow
Date:9/21/2009

NEW YORK, Sept. 21 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) will be hosting an Investor/Analyst Day on Tuesday, September 22nd in New York City beginning at 5:30 pm ET, by invitation only. Scheduled speakers include:

Discussing Perifosine Phase 3 SPA in Multiple Myeloma:

Kenneth C. Anderson, M.D.

  • Director, Jerome Lipper Multiple Myeloma Center and Chief, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute.
  • Dr. Anderson's team at Dana-Farber Cancer Institute led clinical trials in multiple myeloma of the novel proteasome inhibitor Velcade(R), as well as the immunomodulatory drug Revlimid(R).

Discussing Perifosine Phase 2 Results in Colon Cancer:

Johanna Bendell, M.D.

  • Director, GI Oncology Research and Assoc. Director, Drug Development Unit, Sarah Cannon Research Institute.
  • Dr. Bendell has served as an investigator in numerous colorectal trials including capecitabine, oxaliplatin and bevacizumab (XELOX + AVASTIN(R)).

Discussing Zerenex Planned Phase 3 Program in Hyperphosphatemia:

Julia Lewis, M.D.

  • Professor of Medicine, Division of Nephrology, Vanderbilt University School of Medicine.
  • Dr. Lewis has participated in the design and execution of the IDNT Trial, the AASK Trial, the Cohort Study, and HEMO Study, as well as other important clinical trials.

The Investor/Analyst Day presentations will be audio webcast live, accessible from the Investor Information page of the Company's website at http://investors.keryx.com. A
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Keryx Biopharmaceuticals Receives Orphan-Drug Designation for KRX-0401 (Perifosine) for the Treatment of Multiple Myeloma
2. Keryx Biopharmaceuticals, Inc. To Present at the Rodman & Renshaw Annual Global Investment Conference and To Hold Investor/Analyst Day
3. Keryx Biopharmaceuticals Settles License Dispute With Alfa Wassermann
4. Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX-0401 (Perifosine) in the Treatment of Multiple Myeloma
5. Keryx Biopharmaceuticals Inc. Regains Compliance With NASDAQ Listing Requirements
6. Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
7. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2009 Financial Results
8. Keryx Biopharmaceuticals, Inc. Requests an Appeal Hearing After Receiving Notice of Delisting From Nasdaq
9. Keryx Biopharmaceuticals Receives Nasdaq Notification
10. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
11. Keryx Biopharmaceuticals KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Top10BestSEOHosting.com has recently compared many professional web ... ) is one of the best cheap web ... of Top10BestSEOHosting.com states, “It is hard to find ... have outperformed their competitors on hosting features, uptime, ... the best web hosting at affordable prices.” ...
(Date:8/21/2014)... August 21, 2014 Living in a ... atmosphere that comes along with it. A quality Home ... that such amenities are available. , ... Fayetteville, Georgia and Community Association Management, LLC made a ... Parks Company to provide an additional amenity for their ...
(Date:8/21/2014)... arteries of chronic kidney disease patients may be a ... new study in the Journal of the American ... the Johns Hopkins Bloomberg School of Public Health assert ... of subclinical atherosclerosis in predicting the risk of heart ... percent of all patients with chronic kidney disease (CKD) ...
(Date:8/21/2014)... Dallas, TX (PRWEB) August 21, 2014 ... August 20 entertained residents with dementia at Silverado Turtle ... Improv Troupe, which consists of entertainers ranging from ages ... each time they perform their 40-minute set. The troupe's ... makes it universal and allows them to touch audiences ...
(Date:8/21/2014)... California (PRWEB) August 21, 2014 The ... initial plans for entertainment and programming for its inaugural ... On Sunday, October 12, 2014, from 11 a.m. to ... closed to all cars and the downtown will be ... activities, curated by Community Arts Resources (CARS), for all ...
Breaking Medicine News(10 mins):Health News:iPage Reviews Unveiled Online At Top10BestSEOHosting.com 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 3Health News:Measuring calcium buildup to predict heart disease in those with chronic kidney disease 2Health News:Unicorn Clearance Improv Troupe Brings Laughter to Residents with Dementia at Silverado Memory Care 2Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 2Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 3Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 4
... WASHINGTON, Dec. 26 Following is the daily,"Profile America" ... 26: THE BODY,S SECRETS UNLOCKED, Profile America -- ... in history was announced in December eight years ago,the ... 23 pairs of,chromosomes found in human cells have been ...
... It wasn,t that long ago that,pharma companies were ... direction and across the pharma industry companies are now,shrinking ... a constant,state of flux, the fundamentals of selling remain ... it is the practices that reps follow within these ...
... Former Minority Shareholders of Subsidiary to Invest in Nyer ... President of Nyer Medical Group, BANGOR, Maine, Dec. ... today announced that it has reached agreement with the,minority ... acquire the remaining 20% interest in the pharmacy chain ...
... Flexible Purchasing ... of Healthcare Gift Card, PITTSBURGH, Dec. 26 Highmark Inc., ... year,s first,newborns with Prepaid Healthcare Visa(R) Gift Cards, Highmark,s newly,announced product ... associated with, among other life events, the arrival of a,new child. ...
... sites that fire up more when people make impulsive ... alcoholics and non-addicted people making financial decisions, the group ... , The researchers also discovered that a specific gene ... made impulsive choices. The mutation was already known to ...
... transient neurological attacks, such as temporary amnesia or ... and dementia, according to a study in the ... neurological attacks (TNAs) are episodes involving temporary (less ... be nonfocal (that can include nonlocalizing cerebral symptoms), ...
Cached Medicine News:Health News:Pharmaceutical Sales: Best Practices for Pharmaceutical Sales Success 2Health News:Nyer Medical Group Reaches Agreement to Acquire Minority Interest in Pharmacy Chain Subsidiary 2Health News:Nyer Medical Group Reaches Agreement to Acquire Minority Interest in Pharmacy Chain Subsidiary 3Health News:Highmark to Present State's Newest Residents with Healthcare Gift Cards 2Health News:Brain imaging and genetic studies link thinking patterns to addiction 2Health News:Brain imaging and genetic studies link thinking patterns to addiction 3Health News:Some types of temporary neurological problems associated with increased risk for stroke, dementia 2Health News:Some types of temporary neurological problems associated with increased risk for stroke, dementia 3
(Date:8/21/2014)... -- The board of directors of VirtualScopics, Inc. (NASDAQ: ... imaging solutions, today announced that James Groff , ... Mr. Groff has held the role of acting chief ... January 2006 as an accounting manager and was promoted ... board of VirtualScopics asked Jim to assume the role ...
(Date:8/21/2014)... HOUSTON, Aug. 21, 2014  Cyberonics, Inc. (NASDAQ: ... 25, 2014.  Quarterly highlights 1   ... compared to the first quarter of fiscal 2014, and other ... million, an increase of 6.8%; , Strong international net ... constant currency basis; , U.S. net product sales reached ...
(Date:8/20/2014)... , Aug. 20, 2014 Northstar ... announced that after months of hard work from ... the new Snorenz formulation and package design.  The ... and B-6 back into the product due to ... longer lasting effects.  Snorenz Nighttime will also include ...
Breaking Medicine Technology:VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16Northstar completes the first phase of its new retail strategy and prepares to ship reformulated Snorenz with all new packaging 2
... Ala., Nov. 19 BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX ... 5,000,000 shares of its common stock at $9.75 per share, ... the shares are being offered by BioCryst pursuant to an ... Exchange Commission. BioCryst has also granted the underwriters a ...
... , TAINAN, ... global,supplier of active pharmaceutical ingredients (APIs), announced that ... Certification from,SafeBridge(R) Consultants, Inc. The Certification confirms ScinoPharm,s,competency ... active,pharmaceutical ingredients (APIs), and applies to specific laboratories ...
Cached Medicine Technology:BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2
The IntraStent DoubleStrut Biliary Stent represents a completely new direction in stent design. The combination of parallel struts and unique cell geometry provide unparalleled performance....
For the rapid determination of human chorionic gonadotropin (hCG) in urine. The test strip is used to obtain a visual qualitative result....
... GE Healthcares new Vivid i ... cardiovascular ultrasound system to provide high-performance, full-featured ... Vivid i addresses one ... access to complete, real-time diagnostic information. ...
... InstaTest IgE test kit is an immunochromatographic ... levels of immunoglobulin E in human serum ... commonly associated with allergic pathologies. It may ... some infections. Rapid detection of IgE using ...
Medicine Products: